IONS — Ionis Pharmaceuticals Inc

In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Ionis Pharmaceuticals Inc (IONS), worth $165.97M combined. Over the quarter 4 opened or added, 1 trimmed or exited.

Hedge fund holders, 2026 Q2

FundValuePortfolio %Change
Polar Capital$115.29M0.33%+75.3%
Renaissance$44.36M0.06%+83.1%
VanEck$5.03M0.00%+83.7%
BIT$1.29M0.04%NEW

All stocks · Quarterly Trends · Hedge Fund Tracker

Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.